Stockreport

Candel Therapeutics Sets Path to Success: Recent Achievements Pave the Way for a Promising 2024 Propelled by Key Value Drivers and Catalysts [Yahoo! Finance]

Candel Therapeutics, Inc.  (CADL) 
PDF Focusing on strategic key value drivers and catalysts, as a follow up to positive initial clinical and biomarker data in hard-to-treat cancers Advancing the immunothe [Read more]